Melanoma,Skin Cancer Efficacy of Relatlimab and Nivolumab Combination Therapy Examined in Advanced Melanoma Patients Apr 20, 2023
Melanoma,Skin Cancer Neoadjuvant Immunotherapy and Targeted Therapy in BRAF Mutant Resectable Stage III Melanoma Apr 20, 2023
Melanoma,Skin Cancer Superior Efficacy of Nivolumab Plus Ipilimumab in CheckMate 067 for Advanced Melanoma Apr 20, 2023
Melanoma,Skin Cancer Phase 3 Trial: Pembrolizumab as Adjuvant Therapy for Resected Melanoma Mar 07, 2023
Melanoma,Skin Cancer DREAMseq Trial: Efficacy of Treatment Sequence in BRAF V600-Mutant Carcinoma Mar 06, 2023
Melanoma,Skin Cancer Advanced Melanoma: Phase 3 Outcomes of Tumor-Infiltrating Lymphocyte Therapy Mar 06, 2023
Melanoma,Skin Cancer Safety and Efficacy of Neoadjuvant PH-762 in Advanced Melanoma Patients Mar 03, 2023